苏格兰药物联盟批准Kyntheum用于中重度斑块状银屑病患者

2018-05-12 MedSci MedSci原创

苏格兰药品联盟(SMC)已经发布建议,接受在苏格兰境内使用210mg剂量的Kyntheum(brodalumab)

苏格兰药品联盟(SMC)已经发布建议,接受在苏格兰境内使用210mg剂量的Kyntheumbrodalumab)。SMC接受了brodalumab治疗对标准全身治疗无效的成人中度至重度斑块型银屑病的申请。这一批准取决于患者接入方案(PAS),根据该方案,brodalumab以保密折扣或更低的标价提供给苏格兰患者。


英国有将近180万人患有银屑病,据估计,超过160,000人在苏格兰生活,估计有20%的银屑病患者将会发展为中度或严重的疾病。


格拉斯哥大学皮肤科顾问David Burden教授说,这项来自SMC的决定对于患有银屑病的苏格兰人来说是一个重大消息。银屑病的可见症状可能会对患者产生巨大的身体和情感的负面影响。虽然有很多治疗选择,但患者通常需要尝试许多不同的治疗方案来改善他们的病症。与目前可用的其他生物制剂相比,Brodalumab有着不同的分子机制,是现有治疗方案的进一步扩展,因此为我们的患者提供了更多选择

 


原始出处:

http://www.firstwordpharma.com/node/1564763?tsid=28®ion_id=3#axzz5FH0iRO31

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1769750, encodeId=39e81e6975031, content=<a href='/topic/show?id=c7df8e00304' target=_blank style='color:#2F92EE;'>#苏格兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87003, encryptionId=c7df8e00304, topicName=苏格兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat May 19 16:56:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330080, encodeId=43e91330080e2, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449587, encodeId=0356144958ecb, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57934, encryptionId=446f5e934a9, topicName=斑块状银屑病)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ecb5492626, createdName=gous, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496629, encodeId=d968149662986, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1769750, encodeId=39e81e6975031, content=<a href='/topic/show?id=c7df8e00304' target=_blank style='color:#2F92EE;'>#苏格兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87003, encryptionId=c7df8e00304, topicName=苏格兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat May 19 16:56:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330080, encodeId=43e91330080e2, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449587, encodeId=0356144958ecb, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57934, encryptionId=446f5e934a9, topicName=斑块状银屑病)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ecb5492626, createdName=gous, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496629, encodeId=d968149662986, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1769750, encodeId=39e81e6975031, content=<a href='/topic/show?id=c7df8e00304' target=_blank style='color:#2F92EE;'>#苏格兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87003, encryptionId=c7df8e00304, topicName=苏格兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat May 19 16:56:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330080, encodeId=43e91330080e2, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449587, encodeId=0356144958ecb, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57934, encryptionId=446f5e934a9, topicName=斑块状银屑病)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ecb5492626, createdName=gous, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496629, encodeId=d968149662986, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1769750, encodeId=39e81e6975031, content=<a href='/topic/show?id=c7df8e00304' target=_blank style='color:#2F92EE;'>#苏格兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87003, encryptionId=c7df8e00304, topicName=苏格兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat May 19 16:56:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330080, encodeId=43e91330080e2, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449587, encodeId=0356144958ecb, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57934, encryptionId=446f5e934a9, topicName=斑块状银屑病)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ecb5492626, createdName=gous, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496629, encodeId=d968149662986, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon May 14 09:56:00 CST 2018, time=2018-05-14, status=1, ipAttribution=)]
    2018-05-14 zexyw04